| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |